Gerard J. Marek

6.9k citations

106 papers · 5.5k indexed · h-index 37

Impact in

Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in

Cellular and Molecular Neuroscience 82
- Neuroscience and Neuropharmacology Research 55
- Neurotransmitter Receptor Influence on Behavior 53
Biological Psychiatry 6

Co-authors: George K. Aghajanian Lewis S. Seiden Darryle D. Schoepp Ronald S. Duman Vidita A. Vaidya Rebecca A. Wright Georgetta Vosmer Christopher J. McDougle
Journals: Journal of Pharmacology and Experimental Therapeutics (15 papers)European Journal of Pharmacology (7 papers)Neuropharmacology (5 papers)Pharmacology Biochemistry and Behavior (4 papers)Brain Research (4 papers)
Partner nations: United States United Kingdom Russia

In The Last Decade

Gerard J. Marek

106 papers receiving 5.4k citations

Peers

Countries citing papers authored by Gerard J. Marek

Since Specialization

Citations

This map shows the geographic impact of Gerard J. Marek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard J. Marek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard J. Marek more than expected).

Fields of papers citing papers by Gerard J. Marek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard J. Marek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard J. Marek. The network helps show where Gerard J. Marek may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerard J. Marek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerard J. Marek Line = papers co-authored together Gerard J. Marek links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA _B receptor, and morphine in recreational opioid users Journal of Psychopharmacology ·Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J. Marek	2023	1
2	A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder Journal of Psychopharmacology ·Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J. Marek	2023	2
3	The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs Journal of Pharmacology and Experimental Therapeutics ·Gerard J. Marek, Mark L. Day, Thomas J. Hudzik	2015	8
4	APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease Journal of Alzheimer s Disease ·Jeffrey F. Waring, Qi Tang, Weining Robieson, David P. King, Ujjwal Das, Jordan Dubow, Sandeep Dutta, Gerard J. Marek, Laura M. Gault	2015	26
5	Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384 Translational Psychiatry ·David A. Katz, W Liu, C. Locke, Peer B. Jacobson, D M Barnes, Rita Basu, Guohua An, Matthew J. Rieser, Dan Daszkowski, Frank D. Groves, G Heneghan, Ashini Shah, Hakop Gevorkyan, Stanford S. Jhee, Larry Ereshefsky, Gerard J. Marek	2013	12
6	Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades Neuropharmacology ·Hannah K. Delille, Judith M. Becker, Sabrina Burkhardt, Barbara Bleher, Georg C. Terstappen, Martin Schmidt, Axel H. Meyer, Liliane Unger, Gerard J. Marek, Mario Mezler	2012	78
7	Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats Journal of Pharmacology and Experimental Therapeutics ·Agnieszka Nikiforuk, Piotr Popik, Karla Drescher, Marcel van Gaalen, Ana-Lucia Relo, Mario Mezler, Gerard J. Marek, Hans E. Schoemaker, Gerhard Groß, Anton Bespalov	2010	62
8	Awake Rat Pharmacological Magnetic Resonance Imaging as a Translational Pharmacodynamic Biomarker: Metabotropic Glutamate 2/3 Agonist Modulation of Ketamine-Induced Blood Oxygenation Level Dependence Signals Journal of Pharmacology and Experimental Therapeutics ·Chih‐Liang Chin, Jaymin Upadhyay, Gerard J. Marek, Scott Baker, Min Zhang, Mario Mezler, Gerard B. Fox, Mark L. Day	2010	49
9	Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder European Neuropsychopharmacology ·Johannes Tauscher, William Kielbasa, Smriti Iyengar, François Vandenhende, Xiaomei Peng, David Mozley, Donald R. Gehlert, Gerard J. Marek	2009	43
10	The 5-Hydroxytryptamine2A Receptor Antagonist R-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) Attenuates Impulsivity after Both Drug-Induced Disruption (Dizocilpine) and Enhancement (Antidepressant Drugs) of Differential-Reinforcement-of-Low-Rate 72-s Behavior in the Rat Journal of Pharmacology and Experimental Therapeutics ·Paul Ardayfio, Mark J. Benvenga, Stephen F. Chaney, Patrick L. Love, John T. Catlow, Steven P. Swanson, Gerard J. Marek	2008	20
11	Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex Neuroscience Letters ·Gerard J. Marek, Ce Zhang	2008	23
12	5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: Interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740 Neuroscience Letters ·Gerard J. Marek, Rebecca A. Wright, Darryle D. Schoepp	2006	16
13	The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression Neuroscience Letters ·Young-Lim Lee, Ronald S. Duman, Gerard J. Marek	2006	27
14	Developing therapeutics for schizophrenia and other psychotic disorders PubMed ·Gerard J. Marek, Kalpana Merchant	2005	15
15	Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors Pharmacology Biochemistry and Behavior ·Jonathan C. Gewirtz, Andrew C. Chen, Rose Z. Terwilliger, Ronald C Duman, Gerard J. Marek	2002	64
16	LY3 54740: A Systemically Active mGlu2/mGlu3 Receptor Agonist CNS Drug Reviews ·Darryle D. Schoepp, James A. Monn, Gerard J. Marek, George A Ghajanian, Bita Moghaddam	1999	20
17	α1B-Adrenoceptor-mediated excitation of piriform cortical interneurons European Journal of Pharmacology ·Gerard J. Marek, George K. Aghajanian	1996	30
18	Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam Psychopharmacology ·Jerry B. Richards, Karen E. Sabol, Timothy H. Hand, David C. Jolly, Gerard J. Marek, Lewis S. Seiden	1994	23
19	Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report Journal of Child and Adolescent Psychopharmacology ·C. Neill Epperson, Christopher J. McDougle, Amit Anand, Gerard J. Marek, SUSAN T. NAYLOR, Fred R. Volkmar, Donald J. Cohen, Lawrence H. Price	1994	12
20	Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats Pharmacology Biochemistry and Behavior ·Gerard J. Marek, Georgetta Vosmer, Lewis S. Seiden	1990	19

About Gerard J. Marek

Gerard J. Marek is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry, Behavioral Neuroscience, Pharmacology and Cognitive Neuroscience, having authored 106 papers that have together received 5.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (55 papers), Neurotransmitter Receptor Influence on Behavior (53 papers), Receptor Mechanisms and Signaling (27 papers), Psychedelics and Drug Studies (13 papers), Memory and Neural Mechanisms (11 papers), Treatment of Major Depression (11 papers), Hormonal Regulation and Hypertension (9 papers) and Ion channel regulation and function (7 papers). The work is most often cited by research in Biological Psychiatry (718 citations), Cellular and Molecular Neuroscience (4.1k citations), Behavioral Neuroscience (397 citations), Cognitive Neuroscience (1.2k citations) and Clinical Psychology (985 citations). Gerard J. Marek has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include George K. Aghajanian, Lewis S. Seiden, Darryle D. Schoepp, Ronald S. Duman, Vidita A. Vaidya, Rebecca A. Wright, Georgetta Vosmer, Christopher J. McDougle, Lawrence H. Price and G K Aghajanian. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology, Neuropharmacology, Pharmacology Biochemistry and Behavior and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact